Employees Retirement System Of Texas Ionis Pharmaceuticals Inc Transaction History

Employees Retirement System Of Texas

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$31.71 - $43.0 $697,620 - $946,000	22,000 Added 67.88%	54,409 $2.01 Million
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $1.38 Million - $2.07 Million	32,409 New	32,409 $1.46 Million
Q4 2020 Feb 11, 2021	SELL	$45.3 - $60.27 $1.47 Million - $1.95 Million	-32,409 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $684,564 - $836,290	-11,591 Reduced 26.34%	32,409 $1.94 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $620,900 - $861,400	-10,000 Reduced 18.52%	44,000 $2.83 Million
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $211,680 - $324,680	4,000 Added 8.0%	54,000 $4.38 Million
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $471,680 - $590,700	-11,000 Reduced 18.03%	50,000 $2.58 Million
Q2 2018 Aug 10, 2018	BUY	$40.53 - $50.7 $81,060 - $101,400	2,000 Added 3.39%	61,000 $2.54 Million
Q1 2018 May 11, 2018	BUY	$44.08 - $55.05 $1.37 Million - $1.71 Million	31,000 Added 110.71%	59,000 $2.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	28,000	28,000 $1.42 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.